ISS

Search documents
Iran Has More Missiles Than Israel Has Interceptors. Now What? | WSJ
The Wall Street Journal· 2025-06-18 05:41
For days, Israel's defenses have largely held up against Iran's missile attacks. But there's a growing concern that Israel is burning through its defensive weapons. And its aero interceptors, which play a key role in taking out Iran's ballistic missiles, are in short supply, according to a US official.The United States, which has been helping Israel shoot down threats, is also expending its munitions. The US official and analysts familiar with the numbers say that Iran has more missiles than Israel and the ...
High Arctic Overseas Announces Normal Course Issuer Bid
Globenewswire· 2025-06-18 02:17
Core Viewpoint - High Arctic Overseas Holdings Corp. intends to initiate a Normal Course Issuer Bid to repurchase up to 622,408 Common Shares, representing approximately 5% of the total shares outstanding, over a 12-month period from June 20, 2025, to June 19, 2026 [2][4]. Group 1 - The Corporation plans to purchase shares at the prevailing market price, with the actual number and timing of purchases determined by management [2][3]. - Purchases will be conducted on the open market and will be financed from the Corporation's working capital [3]. - The Board of Directors believes the current market price does not reflect the underlying value of the Corporation, making the share repurchase an appropriate use of corporate funds [4]. Group 2 - High Arctic Overseas is a market leader in Papua New Guinea, providing drilling and specialized well completion services, as well as equipment rental solutions [6].
WuXi AppTec Earns SBTi Validation for Near-Term Emissions Reduction Targets
Prnewswire· 2025-06-18 00:00
SHANGHAI, June 17, 2025 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, announced that the Science Based Targets initiative (SBTi) has approved WuXi AppTec's near-term science- based emissions reduction targets. The validation of these targets affirms that the Company's planned reduction in greenhouse gas (GHG) emissions aligns with the goal of limiting global temperature ri ...
Russia Bombards Kyiv in Deadliest Attack on Ukraine Capital in Months
WSJ News· 2025-06-17 15:21
As Ukrainian President Volodymyr Zelensky heads to the G-7, Russia launched its deadliest attack on Kyiv in months, killing at least 15 people with drones and missiles. ...
RTX's Unit Secures a Contract to Aid Standard Missile-6 Program
ZACKS· 2025-06-17 13:16
Key Takeaways Raytheon secured an $18.3M contract for full-rate SM-6 Tactical All-Up Round production. The SM-6 defends against diverse threats and supports 60 naval ships, with 500 units delivered. Work under the contract will occur in Tucson and East Camden, with completion set for May 2029.RTX Corporation’s (RTX) unit, Raytheon, recently secured a $18.3 million modification contract for exercising an option for the manufacturing, assembly, testing and delivery of Standard Missile-6 (SM-6) Tactical All- ...
TotalEnergies Expands U.S. Offshore Footprint by Acquiring New Stake
ZACKS· 2025-06-17 13:10
Key Takeaways TotalEnergies acquired a 25% stake in 40 U.S. offshore leases from Chevron to expand exploration acreage. The deal adds East Breaks, Mississippi Canyon, and Walker Ridge blocks to TTE's U.S. offshore portfolio. It is in sync with TTE's strategy of filling Exploration portfolio with low-cost and low-emission options. TotalEnergies SE (TTE) announced the acquisition of a 25% working interest in a portfolio of exploration leases Offshore U.S. from Chevron Corporation (CVX) . This deal would inc ...
Quantum BioPharma Announces First Person with Multiple Sclerosis (MS) Scanned in Joint Study with Massachusetts General Hospital
Globenewswire· 2025-06-17 12:00
Joint Clinical Study with Massachusetts General Hospital Could Pave the Way for Testing Efficacy of Quantum's Investigational MS drug, Lucid-21-302 TORONTO, June 17, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, announces that the first person with multiple sclerosis (MS) has been scanned in a joint study with Massachusetts ...
Press release: Sanofi successfully prices €1.5 billion bond issue
Globenewswire· 2025-06-17 11:40
Core Viewpoint - Sanofi has successfully priced a €1.5 billion bond issue, which will be utilized for general corporate purposes [1]. Group 1: Bond Issue Details - The bond issue consists of two tranches, each amounting to €750 million [7]. - The first tranche is due in June 2029 with an annual interest rate of 2.625% [7]. - The second tranche is due in June 2032 with an annual interest rate of 3.000% [7]. Group 2: Transaction Management - The transaction was led by Citigroup and RBC Capital Markets as Global Coordinators [2]. - Credit Agricole CIB, HSBC, and Societe Generale acted as Joint Lead Managers for the bond issue [2]. Group 3: Company Overview - Sanofi is an R&D driven, AI-powered biopharma company focused on improving lives through innovative medicines and vaccines [3]. - The company aims to address urgent healthcare, environmental, and societal challenges [3]. - Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY [3].
Fountain Asset Corp. Announces Normal Course Issuer Bid
Globenewswire· 2025-06-17 11:00
Cautionary Statement on Forward ‐ Looking Information Neither the TSX Venture Exchange ("TSXV") nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. This news release contains forward ‐ looking information which involve risks, uncertainties and other factors that could ca ...
What Is Israel's Strategy for Iran?
Bloomberg Television· 2025-06-17 09:08
What is Israel's ultimate strategy here. I think we can know for sure that de-escalation, it's not a strategy that would be considered rather thin gruel as far as the Israelis are concerned, having committed themselves to a very well planned and according to them, very successful so far offensive. So their plans as at the outset, their demands are for an end, whether through their military force or perhaps combined military force for the United States.Time will tell if that will happen or through a negotiat ...